SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 14.21 |
| Enterprise Value ($M) | 0.79 |
| Book Value ($M) | 34.70 |
| Book Value / Share | 1.25 |
| Price / Book | 0.41 |
| NCAV ($M) | 29.68 |
| NCAV / Share | 1.07 |
| Price / NCAV | 0.48 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.27 |
| Return on Assets (ROA) | -0.24 |
| Return on Equity (ROE) | -0.29 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.81 |
| Current Ratio | 5.81 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 37.95 |
| Assets | 42.98 |
| Liabilities | 8.28 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Migdal Insurance & Financial Holdings Ltd. | 5.30 | 0.00 | |
| 13G/A | Phoenix Holdings Ltd. | 8.87 | -4.07 | |
| 13G/A | Armistice Capital, Llc | 4.99 | -31.47 | |
| 13D/A | Arkin Moshe | 60.80 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 1,745,521 | 4,727,426 | 36.92 | |
| 315 | 2,249 | 14.01 | |
| 1,735 | 27,229 | 6.37 | |
| 30,148 | 99,143 | 30.41 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| SGMO – Sangamo Therapeutics, Inc. | SHPH – Shuttle Pharmaceuticals Holdings, Inc. |
| SILO – Silo Pharma, Inc. | SLRX – Salarius Pharmaceuticals, Inc. |
| SLS – SELLAS Life Sciences Group, Inc. |
Financial data and stock pages provided by
Fintel.io